We have now opened up the new release of presentation and discussion materials in the Program area of the InnovationWell web site at http://innovationwell.net/ including new materials from the Autumn 2005 InterAction meetings.
Please note that further release of materials from 2005 will be forthcoming in subsequent releases and that all 2003 and 2004 InnovationWell presentations and discussions are in the process of being moved to the Program areas, so watch out for further news releases here.
List of InnovationWell Seminars currently available in Program areas for Personalised Medicine, Drug Discovery Innovation, Knowledge Management in R&D and Drug Safety:
Personalised Medicine
includes streaming video of Panel Discussion at Bryn Mawr College, Philadelphia
Personalized Medicine: Safety and Efficacy Concerns Discussed as a Case-Study
chaired by Donna Mendrick (Gene Logic) with Discussion Panel: Sydney Gilman (Gene Logic), Matt Cooper (Biogen Idec), Derek Janszen (Wyeth) and Steven Arnold (Queens-Long Island Medical Group)
Drug Discovery Innovation
Structure-Based Design of Allosteric Protein Kinase Inhibitors, Jeff Wiseman (Locus Pharmaceuticals)
An Interactive Environment for Multiparameter Optimization, James H Wikel (Coalesix)
Computational Models are Needed to Make Drugs Safer and More Effective, G. Scott Lett (Bioanalytics Group)
Metabolomics for White Biotechnology, Lars M. Blank (University of Dortmund and the Institute for Analytical Sciences (ISAS), Dortmund )
Is there any Sense in the Semantic Web?, Jim Cook (Volutio)
Knowledge Management in R&D
Knowledge Management Case Study Analysis of a Collaborative Life Science R&D Environment, Jeff Spitzner (Rescentris)
An Interactive Environment for Multiparameter Optimization and Knowledge Management, James H Wikel (Coalesix)
Measuring Knowledge Management via Social Network Analysis, Bonnie Montano (Georgetown University)
Natural Language Processing for Knowledge Extraction in the Life Sciences, Rosemary Polsky-Newman (ExerGen Biosciences)
Managing Knowledge in Breast Cancer: Converting Clinical, Molecular and Imaging Data into Knowledge, Michael Liebman (Windber Research Institute)
Legal Issues in a Knowledge Sharing Environment, James M. Kanagy, Director e-Commerce and Business Method Patents (GlaxoSmithKline)
Knowledge Management Methodologies and Auditing for Electronic Lab Notebook Implementations, Barry Hardy (Douglas Connect) and Jeff Spitzner (Rescentris)
Analysis based on Molecular Diversity, Steve Boyer (IBM)
Assembly, Distribution and Retrieval of Biological Information in Drug Discovery, Kim Henrick (European Bioinformatics Insititute)
Molecular Architecture to Prepare Structures with Desired Properties: The Integration of Databases and Software into the Day-to-Day Practice of a Medicinal Chemist, Ulrich Jordis (Vienna University of Technology)
Strategic Knowledge Management in Life Science Research, Victor Newman (The Knowledgeworks)
Global Roll Out of an Electronic Notebook at Schering AG, Rolf Jautelat (Schering AG)
Drug Safety
Drug Safety Knowledge Management, Barry Hardy (Douglas Connect)
Confidence in Safety, James Averback (Life Science Integration Partners)
Biomedical Informatics used for decision support toward drug safety, Peter L. Elkin (Mayo Clinic)
Talking about Safety, A. Leander Fontaine (Pharmiceutics LLC)
Knowledge Management in Drug Safety – why do we need it?, Sidney N Kahn (PvRM, Inc.)
Drug Safety Innovation Café, Victor Newman (Knowledgeworks)
Designing and Managing a Risk Management Tracking Program, John Clark (Galt Associates)
Ontologies for Pharma, Sheryl Torr-Brown (Pfizer)
Personalized Medicine - integration of bioinformatics and medical informatics for safer and more efficacious healthcare practice and medicine, Peter L. Elkin (Mayo Clinic)
We must build the Knowledge Management Body of Knowledge (KMBOK™), Douglas Weidner (KM Institute)
Capturing and Managing Research Records to support Drug Safety Knowledge Networks, Jeff Spitzner (Rescentris)
The Drug Development Process of the Future, Gene Odle (eValueDrugs)
Symyx IntelliChem's iELN: Meeting the Needs of Intellectual Property; Ronald A. Krasnow and Scott K. Starry (Symyx IntelliChem)
Faceted Classifications: Enabling Effective Information Access, Mark Corderoy (Adiuri Systems Ltd)
Bridging the Gaps: Integrating Systems to improve Drug Safety; Jim Cook (Volutio Ltd)
Applying the Semantic Web to Drug Discovery, Eric Neumann (Sanofi-Aventis, now with w3c)
Perspectives on Drug Safety Knowledge Management, Herschel Weintraub (IBM Life Sciences, now with CambridgeSoft)
Making Personalized Medicine a Reality: Knowledge Management Challenges and Opportunities, Tonya Hongsermeier (Partners Healthcare)
Drug Safety Knowledge Management - Leveraging the Documentation of Safety Labeling Decisions, A. Leander Fontaine (Pharmiceutics LLC)
Building the Drug Safety Body of Knowledge: Safety Hypotheses and Information Sources in the Product Life Cycle, James Averback (Life Science Integration Partners)
What do you do with a Safety Signal?, Sidney N Kahn (PvRM, Inc.)
Barry Hardy
InnovationWell Community of Practice Manager
InnovationWell meeting workshop conference management executive drug safety KM Life Sciences Pharma Drug Discovery Research and Development Drug Development Healthcare Innovation Knowledge Management events
Recent Comments